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Abstract
Recent evidence points to extra-telomeric roles of telomerase in regulating stem
cell function. In this study, human embryonic stem cells (hESCs) were cultured in
20% or 2% oxygen for up to 5 days and evaluated for telomerase reverse
transcriptase (TERT) expression and telomerase activity. Results showed
increased cell survival and maintenance of the undifferentiated state with
elevated levels of nuclear TERT in 2% oxygen cultured hESCs despite no
significant difference in telomerase activity. Pharmacological inhibition of TERT
caused spontaneous differentiation while inhibition of the telomerase RNA
component (TERC) did not. RT-PCR analysis revealed variations in transcript
levels of full-length and alternate splice variants of TERT. Morpholino
oligonucleotides that block specific pre-mRNA TERT splicing events induced
spontaneous hESC differentiation. Together these results suggest that posttranscriptional regulation of TERT under low oxygen could be a selective
advantage for hESC survival and maintenance of the undifferentiated state by
extra-telomeric telomerase isoforms.

Key Words: human embryonic stem cells, microenvironment, telomerase
reverse transcriptase (TERT), telomerase RNA component (TERC), Alternative
splice variants of TERT.
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Chapter 1:
Introduction

1

1.1 Stem cells
Stem cells can be defined as a subset of cells that have the capacity to
self-renew and also give rise to several mature cell types through the process of
cellular differentiation under the appropriate conditions (Uccelli et al., 2008). As
a direct result of these properties, there is a significant potential for the use of
stem cells in regenerative medical applications. Conditions such as Alzheimer’s,
Parkinson’s, immune system deficiencies, anemia, and type I diabetes, are all
candidate diseases suitable for stem cell aided therapy (Hendrix et al., 2007; Kim
et al., 2009). However, before this potential can be realized, a more complete
understanding of stem cell biology is necessary.

As such, a vast body of

research has been devoted to the study of stem cells and the processes that
govern their phenotypic characteristics.
Based on their ability to differentiate, stem cells can be specified into three
broad groups: totipotent, pluripotent, and multipotent stem cells (Figure 1.1)
(Mitalipov et al., 2009; Nakajima et al., 2011). Totipotent stem cells retain the
ability to differentiate into cells representative of all tissues present in an
organism; including those are extra embryonic, such as the placenta. Totipotent
stem cells are typically only found in early preimplantation stage embryos prior to
the formation of the blastocyst and implantation (Mitalipov et al., 2009).
Pluripotent stem cells are derived from the cellular descendants of totipotent
cells, and as such have a reduced capacity for differentiation. Pluripotent stem
cells can develop into any of the cell type representative of the three primaries

2

Figure 1.1.Human development and cell potency. Human development starts
with the union of the male and female gametes (ovum and spermatozoon) at
fertilization to form a zygote. This zygote undergoes many cellular (cleavage)
divisions that eventually lead to exit of the developing embryo from the zona
pellucida membrane and subsequent implantation into the uterine wall. The
blastomeres contained within the early embryo can be considered totipotent,
retaining the potential to develop into the whole organism. As embryo
development progresses to the 8-cell stage and beyond, individual blastomeres
gradually lose their totipotency, eventually resulting in pluripotent, multipotent,
and terminally differentiated somatic cells. Figure adapted from Mitalipov et al.,
2009.
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germ layers: endoderm, mesoderm or ectoderm. However, pluripotent stem cells
are unable to generate extra embryonic cell type such as the placenta.
Multipotent stem cells are derived from pluripotent stem cells and as a result their
capability to differentiate is more restricted (Borge et al., 2002). Multipotent stem
cells can be found in various tissues of adult individuals as well as in the fetus
and umbilical cord. It has been suggested that an adult can contain up to 20
different types of stem cells (Uccelli et al., 2008; Nakajima 2011). These cells
remain in a quiescent or non-dividing state for years until they are activated by
disease or tissue injury to maintain and repair the tissue in which they are found
(Uccelli et al., 2008).
1.1.1 Embryonic Stem cells
Stem cells can be further defined by their differentiation ability and tissuetype of origin.

Embryonic stem cells (ESC) are defined as pluripotent cells

derived from the inner-cell mass (ICM) of the pre-implantation blastocyst
(Thomson et al., 1998). The human blastocyst consists of approximately 70-100
cells and forms at ~5 days post-fertilization. A blastocyst is composed of an
outer sphere of cells referred to as the trophectoderm from which the placenta
will be formed, and an inner compact cell mass called the ICM which contributes
to the formation of all the cells of the body (Figure 1.2).
ESCs were first isolated from mouse (mESC) in 1981 from the ICM of
embryos from inbred mice (Evans et al., 1981; Martin et al., 1981). mESCs were

5

Figure 1.2. Derivation of human embryonic stem cells. The human blastocyst
forms at approximately 4 or 5 days after fertilization and contains from 64 to
several hundred cells. It is comprised of an outer cell layer, the trophectoderm,
and the inner cell mass (ICM). The ICM is harvested either by mechanical
dissociation or by enzymatic digestion of the outer cells and subsequently plated
on mitotically-arrested mouse embryonic fibroblast (MEF) feeder cells, then replated to yield a population of embryonic stem cells. Once established, human
embryonic stem cell lines can persist stably, apparently for years, in a
proliferative state.
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characterized by the ability to self-renew indefinitely in vitro when cultured on
mitotically inactivated mouse embryonic fibroblast (MEF) feeder cell layers in the
presence of leukemia inhibitory factor (LIF) (Williams et al., 1988; Xu et al.,
2002).

The MEF cells were proposed to contribute to ESC derivation and

maintenance through the provision of beneficial factors for the stem cell
microenvironment (Thomson et al., 1998). When cultures were supplemented
with bone morphogenic protein 4 (BMP4) in addition to LIF, mESCs could be
maintained indefinitely on a layer of gelatin, removing the requirement for MEFs
(Williams et al., 1988; Xu et al., 2002).

In addition to these self-renewal

capabilities, mESCs were also demonstrated to be pluripotent through a variety
of assays, such as embryoid body (EB) development in vitro, teratoma formation,
tetraploid complementation, and germ line transmission within in vivo mouse
models. The difference between these ESCs and the cells of the ICM is that the
latter are a transient population within the developing embryo, while the former
are stable in vitro artifacts of the derivation process. Although ESC lines are
typically derived through in vitro explants of the inner cell mass, recent reports
have demonstrated alternative methods for their derivation, such as from single
biopsied blastomeres (Klimanskaya et al., 2006; Geens et al., 2009).
Human ESCs (hESC) were first generated through explant cultures of the
ICM of embryos obtained from in vitro fertilization (Thomson et al., 1998). For
their derivation, the ICM of blastocyst stage embryos was cultured in the
presence of serum and MEFs. hESCs could be maintained indefinitely on these
MEF layers in medium supplemented with basic fibroblast growth factor (bFGF).
8

In contrast to mESCs, hESCs cannot be maintained in an undifferentiated state
in medium supplemented with LIF or BMP4, which has been shown to actually
induce differentiation of these cells (Williams et al., 1988; Xu et al., 2002).
However, in feeder-free conditions, hESCs can be maintained on an extracellular
matrix layer called Matrigel™ in medium pre-conditioned by MEF layers, or in
defined media supplemented with combinations of specific growth factors (Figure
1.2). hESCs are known to have strong expression level for the nuclear cell
markers Oct3/4 and Nanog (Andrews et al., 2005).

Additional differences

between mESCs and hESCs have also been observed during propagation in
vitro related to surface marker expression. Undifferentiated mESCs are known to
express stage specific embryonic antigen (SSEA1), whereas on hESCs this
glycolipid antigen marks differentiated cells.

Opposite trends in SSEA3 and

SSEA4 markers can also be observed, where mESCs (differentiated cells only)
exhibit differential patterns of expression when compared with hESCs
(undifferentiated cells only) (Xu et al., 2002).
Ethical considerations abrogate the use of hESCs in in vivo assays such
as tetraploid complementation or germ line transmission, and as such
pluripotency of hESCs is commonly measured in vitro using embryoid body (EB)
formation, and in vivo by transplantation into immune compromised mice to
evaluate teratoma development. Thus, the ability of hESCs to contribute to the
development of an entire organism remains to be tested. However, in light of
this, the derivation of hESCs and their propagation in in vitro culture was a major
breakthrough not only because of their perceived therapeutic potential, but also
9

for in vitro disease modeling and as a model system for investigating early
developmental events (Thomson et al., 1998).
1.1.2 Induced Pluripotent Stem cells
The ethical considerations surrounding hESCs has prompted researchers
to investigate alternative systems for study in this area. Pluripotency in both
mESCs and hESCs are characterized by the coordinated expression of the core
transcription factors POU5F1 (Oct3/4), Nanog, and Sox2. These three factors
combine to regulate the expression of a large subset of genes related to
maintenance of pluripotency as well as those important for the induction of
differentiation.

It was recently observed that mouse fibroblasts could be

reprogrammed to a cell state indicative of mESCs through retroviral mediated
induction of Oct3/4, Sox2, c-Myc, and Klf4 (Takahashi et al., 2006).

These

reprogrammed cells were referred to as induced pluripotent stem cells (iPSC)
due to their similarities with their embryonic counterparts.

Shortly after the

demonstration of mouse iPSCs, human fibroblasts were reprogrammed by using
different combinations of Oct3/4, Nanog, Sox 2, c-Myc, Lin28, and Klf4
(Takahashi et al., 2007; Park et al., 2008).
Depending on the reprogramming process used, these stem cells will
contain exogenous genetic material used to facilitate expression of the critical
factors. This genetic ‘footprint’ that remains due to genomic integration of the
viral material is an undesirable side-effect of the reprogramming method (Leeb et
al., 2008).

However, active research in the iPSC field has resulted in the
10

generation of ‘footprint-free’ stem cells that do not contain any exogenous
genomic remnants. Although these new methods have helped to overcome one
major hurdle in iPSC research, there are still numerous concerns on the true
equivalency between ESCs and iPSCs, as artifacts of the reprogramming
process resulting from the cell type of which the stem cells are induced have
been described in the literature.
1.2 The Cellular Microenvironment
Outside of the core factors that have been found to be critical for the
maintenance of pluripotency in ESCs, the environment directly surrounding the
cells also plays an important role. This extracellular milieu termed the stem cell
‘microenvironment’

represents

the

immediate

physical

and

chemical

surroundings of a cell. The stem cell microenvironment consists of numerous
components,

including:

soluble

factors,

morphogens, and the extracellular matrix.

support

cells,

oxygen

tension,

The harmonized communication

between these contributors helps to provide the biochemical and mechanical
signals that enable stem cells to survive, proliferate, and differentiate (Li et al.,
2011). Evidence of the effect of the microenvironment can be seen by the drastic
changes observed through modulation of its components in stem cell culture.
The soluble growth factors that are provided to ESCs in culture medium
are critical for maintenance of a pluripotent state (Hynes et al., 2009).

An

example of this is the multiple levels of TGF-β regulation, such as activation
through Activin/Nodal signaling which is known to be one of the core pathways
11

critical for the maintenance of self-renewal and pluripotency of hESCs (Vallier et
al., 2005).

The extracellular matrix provided by MEFs or Matrigel™ is also

essential for preservation of the stem cell phenotype (Hakala et al., 2009;
Hughes et al., 2010). Further environmental effects can also be observed in
other cell systems, where the ability of the microenvironment to reprogram
human metastatic melanoma cells has been observed (Hendrixet al., 2007). An
example of this is the ability of the hESC microenvironment to reduce the
clonegenicity and tumorigenesis potential of metastatic cells by down-regulating
of Nodal expression (Postovit et al., 2008).

Additionally, chicken embryonic

microenvironments have also been observed to have the potential to reprogram
human metastatic melanoma cells to a neural crest cell-like phenotype (Hendrix
et al., 2009). Microenvironmental control can also be observed within the germ
stem cell (GSC) niche (Zhao et al., 2008). In the aging drosophila female, this
stem cell niche undergoes age-dependent loss of GSC presence and activity that
may be due to the deprivation of important signaling factors derived from the
GSC niche (Pan et al., 2007).
Other examples of microenvironmental effects can be seen in adult stem
cell systems, such as in fate determination of mesenchymal stem cells (Tuan et
al., 2002; Hwang et al., 2009). Fate and commitment of mesenchymal stem cells
are regulated by their microenvironment factors, and the resultant effects can
result in alterations in differentiation potential towards different tissues, such as
cartilage and bones (Tuan et al., 2002). However, due to the complexity these
environments represent, it has thus far been challenging to characterize the
12

properties of the microenvironment in order to better understand the dynamic
interaction with stem cells.
1.2.1 The hESC Microenvironment
Microenvironmental regulation starts in early embryogenesis in vivo
resulting directly in control over the processes of cell proliferation and
differentiation (Davey et al., 2006). A similar relationship exists in vitro, where
the characteristics of hESCs are influenced by a complex relationship that exists
between the cells and their surrounding microenvironment (Figure 1.3). In terms
of soluble factors, hESCs are known to respond to a combination of different
growth factors and morphogens. While bFGF is thought to be essential for hESC
maintenance, other factors belonging to the transforming growth factor-β (TGF-β)
family, such as Activins, Nodal, BMPs, and growth determination factors (GDF)
have all been observed to promote preservation or exit from the pluripotent state
( Figure 1.3) (Stewart et al., 2008; Wu et al., 2009).
Other families of soluble factors, such as the Wnt family, have also been
observed to play critical roles in the regulation stem cell behavior in the
microevironment (Sokol et al., 2011; Doble et al., 2007). These pathways are
also known to exhibit a significant amount of cross-talk between one another,
resulting in a dynamic interplay of soluble factors within the stem cell
microenvironment (Sokol et al., 2011). Interestingly, many of the core factors
known to be effectors of the stem cell phenotype have been identified in
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Figure 1.3. Multiple pathways converge to maintain hESC culture
homeostasis. Maintenance of pluripotency of hESC is controlled by specific
growth factors and signaling pathways.
Different molecules in the
microenvironment affect both hESCs and differentiated cells (mouse embryonic
fibroblasts (MEF) feeder cells). Figure adapted from Stewart et al., 2008
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proteomic screens of medium conditioned by MEF layers, suggesting a potential
reasoning behind their benefit in hESC culture. Aside from contributions as a
result of factor secretion into the soluble portion of the microenvironment, support
cells also facilitate attachment in a manner analogous to the extracellular matrix.
The extracellular matrix also can play a direct role on the behavior of stem cells
that is independent of the soluble environment. It has been observed that some
mechanical and physical factors such as matrix stiffness can affect self-renewal
and differentiation of hESCs (Li et al., 2011). As such, there has been a recent
expansion in the development of patterned arrays of extracellular matrix
components in an effort to facilitate elucidation of factors that regulate hESCs
from this non-soluble portion of the microenvironment (Kobel et al., 2010).
Moreover, proteomic studies have illustrated that matrices commonly used in
hESC culture are rich in attachment and growth factor binding proteins, such as
fibronectin (Hughes et al., 2011).
Additionally, it has also been shown that hESCs can secrete morphogens,
such as Left-right determination factors (Lefty) into the extracellular matrix that
can promote a phenotypic change in metastatic melanoma cells (Hendrix et al.,
2007). Proteomic analyses of these secreted matrices has since yielded a rich
data set of potential factors that direct these changes and suggests interaction
between the soluble and insoluble portions of the microenvironment (Hughes et
al., 2011). Taken together, these studies illustrate that the dynamic interplay of
multiple soluble and insoluble factors cooperate to elicit tight control over hESC
behavior in the microenvironment.
16

1.2.2 Oxygen Tensions in Microenvironment
Outside of direct regulation of stem cells by support cells, the extracellular
matrix, or soluble factors, direct control over stem cell fate has been observed to
change with exposure to changing environmental variables such as oxygen.
Oxygen availability is now known to be one of the most important elements of the
microenvironment that has demonstrated roles in embryonic development and
stem cell function (Simon et al., 2008). The majority of focus regarding oxygen
tension in stem cells has modeled changes as a result of exposure to hypoxia.
Hypoxia can be defined as a state where the level of oxygen is decreased
relative to the normal concentration of the dissolved gas, which is approximately
2 – 9% for most mammalian cell types (Paran et al., 1998; Simon et al., 2008).
Hypoxia has been shown to promote the maintenance of a primitive state in
several stem cell and precursor cell populations (Simon et al., 2008). A variety of
different types of adult stem cells reside in a relatively hypoxic microenvironment
when compared to other tissues of the body. For example, hematopoietic stem
cells reside in a physically separated microenvironment from blood vessels
where the oxygen tension is hypoxic (1 – 2%) (Harrison et al., 2002). Neural
stem cells also reside in hypoxic regions (3-4% oxygen) in the brain. It has been
observed that culture of neural stem cells in atmospheric oxygen conditions can
cause mitotic arrest and increased differentiation, whereas culture in hypoxia
revert these effects (Pistollato et al., 2007; Mohyeldin et al., 2010).
Mesenchymal stem cells are also found within tissues that have low oxygen
tensions, and although they are in close proximity to blood vessels their
17

microenvironment is still relatively hypoxic (Grayson et al., 2007; Fehrer et al.,
2007).
1.2.3 ESCs and Hypoxia
Low oxygen microenvironments can generate specific niches for both the
developing embryo, during embryogenesis, and in the adult that regulate cellular
differentiation (Postovit et al., 2008; Dunwoodie et al., 2009). Hypoxia or low
oxygen tension microenvironments show improved in vitro embryo development
of several species including human and mouse (Dumoulin et al., 1998; Orsi et al.,
2001). In the natural environment of hESCs, the human reproductive tract, the
oxygen tension is low (~2%). It has been observed that in in vitro hESC cultures,
low atmospheric oxygen (~4% O2) supports self-renewal as well as decreasing
the amount of spontaneous differentiation (Westfall et al., 2008; Mohyeldin et al.,
2010). Although hypoxia can regulate the pluripotent state in several stem and
precursor cell populations, the molecular mechanisms underlying these
observations remains unclear. One major mode of oxygen-mediated factors is
through hypoxia-inducible factors (HIFs) which play essential role in the cellular
response to oxygen concentration (Patel et al., 2010). Several studies have
shown that HIF have a role in the maintenance of hESC pluripotency
(Szablowska-Gadomska et al., 2011; Quail et al., 2011).
Interestingly, Yu and colleagues established that low oxygen levels
induced the in vivo gene expression of the catalytic subunit of the telomerase
reverse transcriptase (TERT) in fish liver and testis (Yu et al., 2006). In addition,
18

it has been observed that decreasing the oxygen level of the cell culture
microenvironment augments replicative lifespan as well as decreasing the rate of
telomere shortening through an increase in telomerase activity levels in fetal
bovine fibroblasts (Betts et al., 2008). Recent evidence indicates that hESCs
express TERT and the telomerase RNA component (TERC) genes, resulting in
high levels of telomerase activity.

However, following the induction of

differentiation the amounts of TERT, TERC, and telomerase activity decrease
(Yang et al., 2008).
1.3 Telomerase
Due to the end replication problem of DNA polymerase, telomere
shortening occurs at every cell division and limits the proliferative capacity of
human cells to 50–70 cell doublings (Lechel et al., 2004). The enzyme TERT
prevents ongoing telomere shortening by de novo synthesis of telomere repeats.
TERT is a multi-subunit enzyme that adds telomeric sequence repeats
(TTAGGG)n to the 3' ends of all eukaryotic chromosomes. TERT is a reverse
transcriptase that utilizes an RNA molecule (TERC), a non-coding RNA
(451 nucleotides long in humans), as a template to elongate telomeres
(Smogorzewska et al., 2004).
Telomerase activity is mostly found in cells with high-renewal capacity
(stem cells, germline cells) and immortalized cells (cancerous cells) (Kim et al.,
1994; Aubert 2008).Telomerase activity is up-regulated in the large majority of
human tumors compared with normal somatic tissues (Suárez et al., 2001). The
19

high levels of telomerase activity are thought to provide chromosome stability,
telomere length maintenance, and contribute to cellular immortality (Yang et al.,
2008). Normal differentiated human cells lack telomerase activity due to the
stringent transcriptional repression of the TERT gene, and during the oncogenic
process, induction of TERT expression is required for telomerase reactivation
(Lou et al., 2007).
Mutations in TERT cause some disorders and diseases such as Cri du
Chat Syndrome (CdCS), which is an autosomal deletion syndrome that results
from loss of the distal portion of chromosome 5p, where the hTERT gene is
localized (Zhang et al., 2003). Mice lacking telomerase activity show progressive
telomere shortening in consecutive generations, with signs of premature aging
(Lee et al., 1998) and hypertension (Perez-Rivero et al., 2006). Interestingly,
over-expression of TERT in transgenic mice promotes stem cell mobilization and
proliferation in the absence of telomere length alterations (Flores et al., 2005),
suggesting that TERT has non-telomeric functions.
1.3.1 Alternative functions of telomerase
Recent research has revealed alternative functions for telomerase outside
its primary role of synthesizing telomeric repeats. Over expression of TERT can
stimulate cell proliferation (Perrault et al., 2005), alter the cell state towards a
progenitor stem cell-like condition (Lou et al., 2007), and activate stem cell
division, migration, and self-renewal in hair follicle stem cells (Choi et al., 2008).
Notably, telomerase appears capable of activating Wnt/β-catenin signaling by
20

mechanisms independent of telomeric DNA synthesis. Full-length, constitutively
spliced TERT can activate Wnt reporters, and the Wnt axis in vivo and in mESCs
(Park et al., 2009). This action is thought to act through the formation of a TERT
complex that binds to the promoters of Wnt-target genes regulating their
expression.

In addition, TERT has a proposed role in regulating oxidative

damage-induced apoptosis in the mitochondria (Park et al., 2009).
Ectopic expression of TERT and increased telomerase activity enhances
the proliferation and colony-forming ability of hESCs but suppresses the in vitro
differentiation capability to all primitive and embryonic lineages (Yang et al.,
2008).

Conversely, down-regulation of TERT by RNA interference causes

reduced proliferation, loss of pluripotency and induced differentiation in hESCs
(Yang et al., 2008). These recent results indicate an important role for TERT in
maintaining hESC pluripotency, cell cycle regulation, and differentiation capacity.
However, these observations also suggest that TERT induces these effects by
extra-telomeric, non-canonical mechanism(s). Therefore it is critical to enhance
our knowledge about this protein and its related functions.
1.3.2 Alternative splicing system of hTERT transcripts
The human TERT gene contains 16 exons and 15 introns, spans ~40 kb,
where exons 3-11 comprise the reverse transcriptase (Figure 1.4). At least 10
splice variants of hTERT have been recognized and their regulated expressions
appear to contribute to the control of telomerase activity levels (Lou et al., 2007;
Saeboe-Larssen et al., 2006).

Two major deletion variants are depicted in
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relation to hTERT pre-mRNA structure (Figure 1.4). The dominant-negative α
deletion spans 36 bp within exon 6 of the hTERT pre-mRNA. This isoform is
enzymatically inactive and appears to be a dominant inhibitor of telomerase
activity when over-expressed (Figure 1.4) (Colgin et al., 2000). The telomerase
inactive β-deletion spans 182 bp, resulting in deletion of exons 7 and 8 in the
hTERT pre-mRNA causing a truncated enzymatically inactive telomerase variant
of hTERT. Both deletions can combine into an hTERT α- β- deletion variant that
inactivates telomerase activity (Colgin et al., 2000; Anderson et al., 2006).
The splice variants of TERT are expressed in in a number of cancers and
tumour cell lines as well as in early embryos during human development (Ulaner
et al 2001). These splice variants influence telomerase activity levels and cause
variations in telomere length during differentiation (Brenner et al., 1999).
Additionally, they display tissue-specific and gestational age dependent patterns
of expression (Brenner et al., 1999). Splice variants of TERT have also been
observed to be differentially expressed in tumour cells under hypoxic conditions
(Anderson et al., 2006). However, conflicting studies have indicated that there is
no correlation between the levels of alternative splice variants of TERT and the
decrease of telomerase activity during differentiation (Liu et al., 2004; Majerska
et al., 2011).

Collectively, these studies indicate the potential for alternative

functional activities of TERT splice variants.
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Figure 1.4. Genomic structures of hTERT and its alternative splicing. The
human TERT gene contains 16 exons. Exons 3-11 consist of RT domain. The
two major deletion sites are depicted in relation to hTERT mRNA structure. The
dominant-negative α deletion spans 36 bp within exon 6, while β deletion spans
182 bp resulting in deletion of exons 7 and 8 within the reverse transcription (RT)
domain. Figure adapted from Anderson et al., 2006
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1.4 Rationale
The proliferation and colony forming ability of hESCs is increased by the
over-expression of full-length TERT (Yang et al., 2008). Conversely, the downregulation of all TERT transcripts by RNA interference causes reduced ESC
proliferation and spontaneous differentiation (Yang et al., 2008).

Functional

telomerase has been identified in the cytoplasm or in mitochondria of cells
(Ahmed et al., 2008; Martinez et al., 2011). However, the significance of its
cytosolic function is presently unknown.

Recent reports propose TERT as a

regulatory molecule that modulates transcription and implicates telomerase as a
cofactor that acts in a progenitor cell context to facilitate a Wnt-regulated
program of self-renewal, proliferation, or survival (Park et al., 2009). Many of
these extra-telomeric roles of telomerase appear to not require its reverse
transcriptase activity (Park et al., 2009; Chung et al., 2005).
Alternate splice variants of TERT have been abundantly detected in early
preimplantation stage embryos, various tissues during fetal development and in
many cancer and tumour cell lines.

The observed non-canonical functions of

TERT (Park et al., 2009; Ahmed et al., 2008; Martinez et al., 2011) necessitates
further investigation of potential alternative roles for TERT splice variants beyond
modulating telomerase activity levels (Liu et al., 2004; Majerska et al., 2011).
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1.5 Hypothesis
Alternate splice variants of TERT have extra-telomeric roles in the maintenance
of hESC pluripotency and self-renewal.
To address this hypothesis, three integrated aims of study are proposed:
1.

To determine the effects of hypoxia microenvironments on
proliferation,

pluripotency

and

levels/distribution

of

telomerase/TERT in human embryonic stem cells.
2.

To elucidate the effects of pharmacological inhibition of the
telomerase TERT or TERC subunits on human embryonic stem
cell state.

3.

To characterize hypoxia-induced regulation of TERT splice
variant expression in human embryonic stem cells by modifying
TERT

splicing

events

using

steric

blocking

antisense

Morpholinos.

Herein, we investigated the roles of TERT, TERC, and subsequent telomerase
activity in hESCs. To investigate microenvironmental contributions, we analyze
TERT and telomerase expression and localization in hypoxic conditions.
Additionally, we utilize small molecule and mediated inhibition of TERT and
TERC to determine the individual roles of the individual components of
telomerase activity.

Lastly, we employed blocking antisense morpholino

oligonucleotides to characterize the contribution of individual TERT splice
variants in maintaining the undifferentiated state. Our findings show that extratelomeric TERT is one of the essential mechanisms/effectors through which
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hypoxia modifies cell potential and proliferation of hESCs.

Additionally, we

observe that post-transcriptional regulation of TERT has extra-telomeric means,
which promote the self-renewal and pluripotency of hESCs through specific
splice variants of TERT.
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Chapter Two:
Materials & Methods
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2.1 Human Embryonic Stem Cell Culture
H9 hESCs passage 25 (WiCell, Wisconsin) were cultured in six-well
tissue culture plates on a monolayer of CF-1 irradiated mouse embryonic
fibroblast (MEF) feeder layers (GlobalStem, Rockville, MD).

Irradiated MEFs

were plated at a density of 250,000 cells per well of a 6-well gelatin coated
culture dish. Prior to plating of hESCs on MEFs, wells were rinsed with hESC
medium

composed

of

Knockout

Dulbecco's

modified

eagle's

medium

(DMEM/F12), 20% Knockout serum replacement (KOSR), 1% non-essential
amino

acids,

2mM

glutamine

(CellGro,

Manassas,

VA),

0.1

mM

2-

mercaptoethanol (Fisher, Toronto, Canada), and 4 ng/mL of basic fibroblast
growth factor (bFGF).

H9 hESCs were grown in hESC medium in all

experiments where MEF feeder cells were utilized. Cultures were incubated at
37°C in 5% CO2 and the medium was changed daily. hESCs were passaged
mechanically using a glass pick every 5-7 days as required. All media were
passed through 0.22µm filters for sterilization prior to use. All reagents were
obtained from Life Technologies (Grand Island, NY) unless noted otherwise.
2.2 Feeder-free hESC Culture
For experimentation, hESCs were passaged to feeder-free conditions to
limit transmission of MEF cellular material to analyzed samples.

For

immunofluorescence, flow cytometry, RNA extraction, Telomerase Repeat
Amplification Protocol (TRAP) assay, pharmacological inhibition of the catalytic
component (TERT) and RNA component (TERC), and antisense Morpholino
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Oligo (MO) deliveries experiments, H9 hESCs were cultured in feeder-free
conditions.

For feeder-free growth, culture dishes were coated with a 1:30

Matrigel™ (Growth Factor Reduced, BD Biosciences, Franklin Lake, NJ): DMEM
mixture and placed at 37°C to promote gelation. hESCs on Matrigel™ were
cultured using hESC medium (as above) that had been pre-conditioned
(according to previously established protocols (Xu,2001)) on MEF feeder layers
(MEF-CM) and supplemented with a further 8 ng/mL of bFGF, or in commercially
obtained mTeSR1 defined hESC medium (StemCell Technologies, Vancouver,
Canada). For normoxia (20% oxygen tension) and hypoxia (2% oxygen tension)
experiments, H9 hESCs grown in feeder-free conditions were transferred to a
37°C, 5% CO2 environment containing either 20% or 2% oxygen respectively. All
reagents were obtained from Life Technologies (Grand Island, NY) unless noted
otherwise.
2.3 RNA extraction and quantification
H9 hESCs grown in feeder-free conditions in under normoxia (20%
oxygen tension) and hypoxia (2% oxygen tension) were harvested from 6-well
dishes for RNA extraction.

RNA was extracted using TriZOL® reagent (Life

Technologies) according the manufacturer’s instructions. Briefly, an appropriate
number of cells (approximately 106 cells) were reconstituted in 1 mL of TriZOL
reagent and incubated for 10 minutes after vigorous shaking. Chloroform (200
µL, Fisher, Toronto, Canada) was then added to each tube and the mixture
incubated for 10 minutes after vigorous shaking.

The tubes were then

centrifuged for 15 minutes at 12,000 x g at room temperature. The aqueous
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phase was removed and transferred to a fresh tube containing an appropriate
amount of isopropanol (500µl). Tubes were shaken and then incubated for 10
minutes, followed by centrifugation at 12,000 x g for 60 minutes at room
temperature.

The resulting pellets were rinsed with 70% ethanol prior to

reconstitution in nuclease free water (50µl). RNA recovery was quantified using
a NanoDrop 2000 Spectrophotometer (Thermo Scientific, Logan, UT).
2.4 Real-time RT-PCR
For

reverse

transcription

reactions,

the

High

Capacity

Reverse

Transcription Kit with RNase inhibitor (Life Technologies) was utilized. 1μg of
RNA based on NanoDrop quantification was reverse transcribed to cDNA
according to the manufacturer’s instructions. The reaction was carried out in a
BioRad Cl000 Thermal Cycler with the following cycle parameters: 25°C for 10
minutes, 37°C for 2 hours, 85°C for five minutes, and 4°C hold. For RT-PCR
experiments that utilized TaqMan® gene expression assay pre-designed FAM
labeled probes, the TaqMan® Universal PCR Master Mix was utilized (Life
Technologies).

For all experiments where custom primers were used with

SYBR® green detection, the Universal SYBR® Green Master Mix was used:
primers are: TERT-2164S: (GCCTGAGCTGTACTTTGTCAA) and TERT-2620A:
(CGCAAACAGCTTGTTCTCCATGTC) with an initial heating at 94°C for 90 s,
followed by 35 cycles of 95°C for 25 s, 68°C for 50 s, and 72°C for 50 s. which
targeted regions that contained the α and β splice sites. The remainder of the
primers and RT-PCR assay information can be found in Table 1. For real-time
RT-PCR, the samples were placed in a Cl000™ Thermal Cycler (BioRad,
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Mississauga, Canada) and incubated at 50°C for 2 minutes followed by 10
minutes at 95°C. Samples were then amplified at 95°C for 15 seconds followed
by 1 minute at 58°C for 46 cycles.
All samples were normalized to the large ribosomal protein RPLPO as an
internal control, and fold changes calculated using the delta-delta-CT method.
The following equation was used to calculate fold difference based on CT values
(Pfaffl 2001):
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Table 1. Real Time PCR Primer Information. List of all primers used in realtime PCR experiments.
Target
alpha-fetoprotein

Assay ID
Hs00173490_m1

NCBI Gene Reference
NM_001134.1

GATA binding protein 4

Hs00171403_m1

NM_002052.3

T, brachyury homolog (mouse)

Hs00610080_m1

NM_003181.2

GATA binding protein 6

Hs00232018_m1

NM_005257.3

paired box 6

Hs01088112_m1

NM_001127612.1

neurogenic differentiation 1

Hs00159598_m1

NM_002500.2

Pou class 5 homeobox 1

Hs00742896_s1

NM_203289.3

Nanog homeobox

Hs02387400_g1

NM_024865.2

caudal type homeobox 2

Hs01078080_m1

NM_001265.3
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2.5 Immunofluorescence
Culture dishes of H9 hESCs grown in feeder-free conditions in 20% or 2%
oxygen were rinsed twice in PBS and incubated in fixing solution containing 4%
paraformaldehyde in PBS for 15 minutes at room temperature. For intracellular
staining, fixed cells were rinsed and subsequently permeabilized with 0.1% Triton
X-100 in PBS for 15 minutes. Blocking of fixed cells was performed using Dako
Serum Free Protein Block solution (Dako, Carpinteria, CA) according the
manufacturer’s instructions. Cells were then incubated with one of the primary
antibodies against Oct-4 (Mouse anti-human/mouse monoclonal, 1:500 dilution of
manufacturer stock, clone 10H11.2, Millipore, Billerica, MA), SSEA4 (mouse antihuman monoclonal, 1:500 dilution of manufacturer stock, clone MC-813-70,
Millipore), SSEA1 (mouse anti-human/mouse monoclonal, 1:500 dilution of
manufacturer stock, clone MC-480, Millipore), or TERT (rabbit anti-human
polycolonal, 1:100 dilution of manufacturer stock, Rockland, Gilbertsville, PA).
Incubation time for all primary antibodies was 1 hour, in PBS containing 0.1%
bovine serum albumin, at room temperature.

After rinsing, the cells were

incubated with secondary antibodies specific for the chosen primaries.
Secondary antibodies Alexa-fluor 488 goat anti-mouse IgG, Alexa-fluor 568 goat
anti-mouse IgM (Life Technologies) and

goat anti-rabbit IgG fluorescein

conjugate (Calbiochem, San Diego, CA) were all used at 1:2000 dilutions in PBS
containing 0.1% bovine serum albumin, of manufacturer stocks.

Cells were

incubated in secondary antibody solutions for two hours at room temperature and
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then rinsed three times with PBS. Images obtained immediately while fixed cells
remained in PBS.
2.6 Flow Cytometry
H9 hESCs grown in feeder-free conditions in 20% or 2% oxygen were
harvested using Accutase® (Life Technologies) to obtain a single cell suspension.
After centrifugation, hESC pellets were resuspended in 5% fetal bovine serum
(FBS) in phosphate buffered saline (PBS).
(EBiosciences,

San

Diego,

CA)

and

Alexa-488 conjugated SSEA-4
Alexa-647

conjugated

SSEA1

(EBiosceinces), were added to the suspension based on approximate cell
number according to the manufacturer’s instructions and incubated for one hour
at 4°C.

After rinsing, cells were directly analyzed using an Accuri C6 flow

cytometer (BD Biosciences). For TERT experiments, harvested cells were fixed
in 4% paraformaldehyde in PBS for 10 minutes and subsequently permeabilized
using 0.1% Triton X-100 in PBS.

After rinsing, cells were incubated in

telomerase specific primary antibody (mouse anti-human monoclonal, clone 2C4,
1:500 dilution of manufacturer stock, Abcam, Cambridge, MA). Primary antibody
incubations were carried out for 1 hour in 5% FBS in PBS at 4°C. After rinsing,
cells were incubated with an appropriate secondary (goat anti mouse polyclonal,
Abcam, Cambridge, MA). Representative negative control samples contained
isotype controls for the primary antibodies used. Secondary antibodies were
incubated for 2 hours at 4°C. After rinsing, cells were directly analyzed using an
Accuri C6 flow cytometer (BD Biosciences). Populations were gated according
to forward and side scatter patterns with filtering for viable cells using 735

aminoactinomycin D stain added just prior to analysis. Data were analyzed using
FlowJo software (Tree Star, Ashland, OR).
2.7 Real time quantitative telomeric repeat amplification protocol (RQTRAP)
Telomerase activity was measured by the fluorescent telomeric-repeat
amplification protocol (TRAP assay) with the TRAPeze® RT Telomerase
Detection kit (Chemicon International, Temecula, CA) according to the
manufacturer’s instructions. Briefly, cultured H9 hESCs, were lysed in CHAPS
buffer for 30 minutes on ice and centrifuged at 12,000 x g for 20 minutes at 4°C.
Protein concentrations were determined using the BCA protein assay (Pierce,
Rockford, IL).

Telomerase activity was assayed using 2 μg of protein per

reaction, and experiments performed in triplicate. For all experiments, human
embryonic kidney cells (HEK293T) were used as a positive control and human
dermal fibroblast (hDF) as a negative control. Telomerase, if present in the cell
extract, will add telomeric repeat sequences (TTAGGG) sequences to the 3’ end
of an oligonucleotide substrate.

The number of repeat sequences added by

telomerase is quantified using real-time PCR by measuring the increase in
SYBR® green fluorescence upon binding to DNA. The parameters for real-time
PCR were: 30 minutes at 30ºC, 2 minutes at 95ºC, followed by 45 cycles of 94ºC
for 15 seconds, 59ºC for 60 seconds, and 45ºC for 10 seconds.
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2.8 Antisense Morpholino Oligo (MO) blocking of TERT splicing events
Antisense morpholino oligos (MO; Gene Tools, LLC, Philomath, OR)
complementary to specific exon-intron or intron-exon boundaries of the premRNA sequence of TERT were used to specifically block the splicing of the α(intron 5/exon 6) and β-splice (exon 8/intron 8) variants of TERT (Figure 2.1).
Morpholinos that contained no specificity to any transcript were used as controls.
These morpholinos were fluorescently tagged to allow convenient visualization
using microscopy, permitting measurement of transfection efficiency.

hESCs

were transfected by passaging them in the presence of the morpholino. Briefly,
hESC cells cultured on a MEF-feeder layer were picked up mechanically into
mTeSR1 medium containing 20 µM of each morpholino (α-MO, β-MO) and then
transferred to feeder-free conditions under 5% CO2 in air atmosphere. hESCs
were fed daily with mTeSRl that was contained 20 µM of each morpholino, for
three days. Treated hESCs were subsequently processed for RNA extraction
and quantification, and assayed by real-time RT-PCR, immunofluorescence, and
flow cytometry.
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Figure 2.1 Morpholino oligonucleotides design for blocking α-, β-TERT
splice variants. The morpholino oligonucleotide (MO) sequences designed from
5’ to 3’, and complementary to specific intron-exon or exon-intron boundaries of
the pre-mRNA sequence of TERT, that blocks the alternate splice sites α- (intron
5/exon 6) and β- (exon 8/intron 8) of TERT.
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2.9 Pharmacological inhibition of the catalytic component (TERT) and RNA
component (TERC) of telomerase in hESCs
Telomerase Inhibitor IX (Calbiochem) is a cell-permeable compound,
containing m-phenylenediamide that inhibits the catalytic component (TERT) of
telomerase (Seimiya 2002).

Telomerase Inhibitor III (Calbiochem) is a cell-

permeable hexameric phosphorothioate oligonucleotide (PS-ODN) compound
that can recognize and bind to the telomerase RNA component (TERC) resulting
in inhibition of telomerase activity (Pitts, 1998). H9 hESCs were grown on six
well plates in feeder-free conditions in the presence of either Telomerase
Inhibitor IX (10µM, 20µM) or Telomerase Inhibitor III, (3µM, 5µM), in MEF-CM.
hESCs were fed daily with MEF-CM that was supplemented with the
corresponding inhibitor for three days.

Treated hESCs were subsequently

assayed using immunofluorescence and flow cytometry.
2.10 Statistics
For all experiments, statistical analyses were performed using Microsoft
Excel 2010 or Graph Pad Prism software. Results are expressed as SD and
three technical and biological replicates as indicated in figure legends. Statistical
significance was determined using unpaired Students T-tests. Parametric data
was analyzed by a one-way ANOVA followed by a post-hoc TUKEY’s test using
Graph Pad Prism 5 software, while nonparametric data was analyzed by a oneway ANOVA on ranks followed by a post-hoc Dunn’s test using Sigma Stat 3.5.
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Statistically significant data was indicated if the P-value was 0.05 or less
(p<0.05).
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Chapter Three:
Results
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3.1 Hypoxia promotes cell viability and maintenance of the undifferentiated
state in hESCs
Proliferation and maintenance of the pluripotent state in hESCs is
enhanced by culture in low oxygen conditions (Westfall et al., 2008). During in
vitro culture and expansion, hESCs have a tendency to spontaneously
differentiate.

This phenomenon has previously been attributed to suboptimal

culture conditions, including the use of atmospheric oxygen environments. In
contrast, hypoxic environments (2-5% oxygen tensions) prevent spontaneous
differentiation and support self-renewal of hESCs (Ulaner et al., 1998). Based on
these findings, we utilized both high (20%) and low (2%) oxygen hESC
microenvironments to correlate the abundance and localization of TERT, and
resultant telomerase activity levels with hESC proliferation and maintenance of
the undifferentiated state.
Human ESCs were cultured in feeder-free conditions on Matrigel™ under
conditions of normoxia (20% O2) and hypoxia (2% O2) for a total of 96 hours. To
control for culture variability resulting from colony starting size, cells treated in
normoxic and hypoxic conditions were derived and split from the same
population of hESCs. To be consistence in the hESC attachment, they stayed in
normoxia conditions for 24 hours after passage to attach in same conditions
(Figure 3.1A), then they were moved to either a hypoxia or normoxia culture
condition. After total 96 hours, we observed hESCs in normoxia and hypoxia that
displayed sharp edges and consisted of uniform colonies of compact cells
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Figure 3.1 - Low oxygen promotes cell viability of hESCs. hESCs were
grown in feeder-free conditions in hypoxia (2% O2) and normoxia (20% O2) for a
total of 96 hours. (A) Phase contrast microscopy images of H9 hESCs cultured
in hypoxia and normoxia conditions. Scale bars represent 200µm. (B)
Histogram depicting relative colony area measurements of hESCs in hypoxia and
normoxia. For each oxygen condition, 3 wells from 6-well plates were counted
for 3 different experiments. Colonies were selected in each well by computer
software and the average intensity graphed. Error bars represent SD, n=3,
*p<0.05. (C) Flow cytometry analysis measuring viable cell counts between
hESC cultures grown in hypoxia and normoxia. Viability was determined using 7AAD staining. Cell populations were gated based on 7-AAD exclusion (7-AAD
exclude of nonviable cells in flow cytometric assays), graphs shows 7-AAD
fluorescence in hypoxia, blue, relative to normoxia, red. (D) Mean fluorescence
intensity plots derived from flow cytometry data representing number of alive
cells by 7-ADD signal of hESCs grown in hypoxia and normoxia. Error bars
represent SD, n=3, *p<0.05.
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(Figure 3.1A).

However, in normoxia we observed an increased number of

colonies relative to hypoxia that contained regions of cells that had a flat and
elongated morphology, consistent with cellular differentiation (Figure 3.1A).
(Figure 3.1A).

From measurements of colony area we observed that hESC

colonies in hypoxia were on average ~2X larger when compared to those in
normoxia (Figure 3.1B). To further investigate the apparent hESC growth rate
differences under varying oxygen microenvironments, flow cytometry was
performed to determine accurate viable cell counts. We observed a decrease in
the incidence of cell death, as indicated by 7-Aminoactinomycin D (7-AAD)
staining, in hypoxia compared to normoxia (Figure 3.1C, D). Taken together,
these observations illustrate that hESCs grown in low oxygen have increased cell
numbers when compared with those cultured in higher oxygen conditions.
To examine the cellular changes related to pluripotency/differentiation
status between hESC cultured in hypoxia and normoxia, hESCs were examined
by immunofluorescence for the levels of pluripotency marker POU5F1 (herein
referred to as Oct3/4), and for the cell surface differentiation marker, stage
specific

embryonic

antigen

1

(SSEA1).

Oct3/4

is

characteristic

of

undifferentiated hESCs, whereas SSEA1 is typically only found expressing in
hESCs that have initiated differentiation (Lin et al., 2011). Cultures maintained in
normoxic and hypoxic conditions both contained uniform distributions of Oct3/4
fluorescence within hESC colonies (Figure 3.2A).

However, hESC colonies

grown in normoxic cultures contained cells with visible amounts of SSEA1
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Figure 3.2 - Hypoxia promotes maintenance of an undifferentiated state in
hESCs. hESCs were grown in feeder free conditions in hypoxia (2%) and
normoxia (20% O2) for a total of 96 hours. (A) Immunocytochemistry detection of
Oct3/4 and SSEA1 in hESCs cultured in 2% or 20% oxygen for 96 hours. Scale
bars represent 200µm. (B, C) Densitometric analysis of fluorescent intensities
revealed the relative culture area occupied by Oct3/4 and SSEA1 expressing
cells in hypoxic and normoxic cultures. Scale bars represent SD, n=3. (D) Flow
cytometry data plots representing fluorescence signal for hESC populations
harvested from normoxic and hypoxic cultures. Cells were assayed for Oct3/4
and SSEA1. (i, ii) Scatter plot with the gated cell population shown for 2% and
20% oxygen. Populations were gated based on morphology and comparison to
their matched isotope control and viability, according to forward scatter (FSC)
and side scatter (SSC) pattern. (Forward Scatter measures cell size and Side
Scatter measures complexity). Oct3/4(iii) and SSEA1(iv) fluorescence in 2%
(blue) and 20% (red) oxygen conditions relative to matched isotype controls
(black). Viability was determining using 7-AAD staining. Mean fluorescence
intensity plots derived from flow cytometry data representing Oct3/4 (E) and
SSEA1 (F) signal intensities of hESCs grown in hypoxia and normoxia. Error
bars represent SD, n=3, *p<0.05.
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fluorescence relative to hESCs cultured in hypoxia (Figure 3. 2A). Densitometric
examination of immunofluorescent signal intensities was performed to quantify
the relative fluorescent pixel strength.

There was no significant difference

between the relative areas occupied by Oct3/4 expressing cells between the two
conditions (Figure 3.2 B). However, cultures grown in normoxia (20% oxygen)
contained significant (p<0.05) relative culture area occupied by hESCs
expressing SSEA1 (Figure 3.2 C). Flow cytometry analysis indicated that the
number of SSEA1 expressing cells was increased in normoxic hESC cultures
relative to hypoxic (Figure 3.2 D, F). However, based on mean fluorescence
intensity, flow cytometry data indicated a decrease in Oct3/4 fluorescence in
normoxic hESC cultures relative to those in hypoxia (Figure 3.2 D, E). Taken
together, these data indicate that culture of hESCs in a relatively hypoxia (2%
oxygen) microenvironment promotes maintenance of an Oct3/4-positive and
SSEA1-negative undifferentiated cellular state.
3.2 Hypoxia increases TERT levels and promotes it nuclear localization
without significant changes in telomerase activity
Based on our confirmatory findings, we utilized these high and low oxygen
microenvironments to investigate the potential molecular mechanisms behind the
maintenance of hESC self-renewal and pluripotency.

Previous studies have

suggested that hESCs express TERT and have subsequently high levels of
telomerase activity that are reduced upon their spontaneous differentiation (Yang
et al., 2008). To investigate these observations further, we next sought to
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Figure 3.3 - Hypoxia (2% oxygen) promotes the nuclear translocation of
elevated TERT levels in hESCs, despite no significant difference in
telomerase activity. hESCs were grown in feeder-free conditions in relatively
hypoxic and normoxic microenvironments to monitor TERT protein abundance
and localization, as well as telomerase activity. (A) Immunofluorescence of TERT
localization patterns and protein levels in hESCs cultured on Matrigel in 2% and
20% oxygen. Dashed circles denote single cells, and arrows point to areas of
TERT protein abundance within cells. (B) Flow cytometric analysis measuring
TERT fluorescence levels in H9 hESCs cultured in 20% and 2% oxygen. (i, ii)
Scatter plots with the gated cell population shown for 2% and 20% oxygen.
Populations were gated based on morphology and comparison to their matched
isotope control and viability, according to forward scatter (FSC) and side scatter
(SSC) pattern. (Forward Scatter measures cell size and Side Scatter measures
complexity). (iii) TERT fluorescence in 2% (blue) and 20% (red) oxygen
conditions relative to matched isotype controls (black). Viability was determining
using 7-AAD staining. (C) Mean fluorescence intensity plots derived from flow
cytometry data representing TERT signal of hESCs grown in hypoxia and
normoxia. Error bars represent SD, n=3. (D) Relative telomerase activity in
hESCs cultured in 2% or 20% oxygen. Error bars represent SD, n=3, three
independent experiments performed. Different characters indicate significant
differences (p<0.05).
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determine whether the hESC growth and differentiation changes observed in
hypoxia and normoxia correlated with telomerase activity levels, TERT protein
abundance, and TERT localization in hESCs cultured under high and low
oxygen.

Immunocytochemical analyses indicated that TERT protein was

elevated and localized predominantly within the nuclei of hESCs when cultured in
hypoxic conditions, but displayed a perinuclear/cytoplasmic localization pattern in
cells grown in normoxia after both 4 and 6 days of culture (Figure 3.3A). Flow
cytometric analysis indicated a significant (p<0.05) increase in TERT levels in
hESCs cultured in hypoxia when compared with those cultured in normoxia after
5 days (Figure 3.3 B,C). To evaluate whether the observed increase in TERT
protein levels affected the amount of telomerase activity, the RQ-TRAP assay
was performed on hESCs cultured in normoxia and hypoxia for 5 days.
Interestingly, elevated TERT protein did not result in increased telomerase
activity levels in hESCs, as there was no significant difference (p>0.05) between
the measured quantities from the three populations examined (Figure 3.3 D).
Overall, these findings indicate that low oxygen culture conditions promote the
nuclear localization of elevated TERT levels in hESCs compared to those
cultured in higher 20% oxygen without a significant alteration in the quantity of
telomerase activity.
3.3 Pharmacological inhibition of the catalytic TERT subunit of telomerase
induces spontaneous hESC differentiation.
Although recent evidence indicates that hESCs express TERT and TERC
subunit genes, recent studies have shown that TERT overexpression in mouse
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Figure 3.4 – Small molecule inhibition of TERT induces spontaneous hESC
differentiation. H9 hESCs were grown in feeder-free conditions in 20% and 2%
oxygen following treatment with TERT inhibitor for 3 days. (A)
Immunofluorescence detection of Oct3/4 and SSEA1in hESCs treated with 20µM
of TERT inhibitor for 3 days in hypoxia. Scale bars represent 200µm. (B)
Relative telomerase activity levels of whole-cell lysates as measured by the Realtime Quantitative TRAP (RQ-TRAP) assay. Error bars represent SD, n=3.
Different characters indicate significant differences (p<0.05). (C) Flow cytometry
data plots representing fluorescence signal for hESCs treated with 20µM of
TERT inhibitor (TI-IX), and non-treated cells in hypoxia (as control) for 3 days in
2% oxygen. Cells were assayed for Oct3/4 and SSEA1. (ii,i) Scatter plots with
the gated cell shown for both cell populations. Populations were gated based on
morphology and comparison to their matched isotope control and viability,
according to forward scatter (FSC) and side scatter (SSC) pattern. (Forward
Scatter measures cell size and Side Scatter measures complexity). SSEA1(iii),
and Oct3/4 (iv) fluorescence shown in 2% oxygen conditions (blue) and control
(red) relative to matched isotype controls (black). Viability was determining using
7-AAD staining. (D, E) Mean fluorescence intensity plots derived from flow
cytometry data representing Oct3/4 and SSEA1 signal of hESCs treated with
10µM and 20µM of TERT inhibitor for 3 days in 2% and 20% oxygen. Error bars
represent SD, n=3. Different characters indicate significant differences (p<0.05).
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epidermis stem cells activates stem cell division, migration, and self-renewal that
is independent of TERC (Choi et al., 2008 ; Yang et al., 2008). To build on our
previous data demonstrating that TERT protein abundance is significantly altered
independent of telomerase activity in hypoxia relative to normoxia cultures, we
investigated the potential roles for TERT and TERC in hESCs. To undertake
this, we utilized the small molecule inhibitors Telomerase Inhibitor IX (TI-IX,
TERT inhibitor) and Telomerase Inhibitor III (TI-III, TERC inhibitor) that are
specific for TERT and TERC, respectively (Seimiya et al., 2002; Pitts et al.,
1998).
Based on pilot study and concentrations previously used on human cells
that effective inhibited telomerase activity (Seimiya et al., 2002; Pitts et al., 1998),
optimization of inhibitor concentrations in hESCs cultured in normoxia and
hypoxia conditions indicated that TERT and TERC inhibitors were most effective
at 20µM and 5µM, respectively (data not shown).

H9 hESCs were treated with

20µM TERT inhibitor and analyzed by immunofluorescence to detect the levels of
pluripotency marker Oct3/4 and differentiation marker SSEA1. In normoxic and
hypoxic cultures supplemented with TERT inhibitor, we observed noticeable
fluorescence for SSEA1 coupled with a decrease in Oct3/4 levels, indicating that
hESCs were spontaneously differentiating (Figure 3.4A).

These data were

further validated through flow cytometry of normoxic and hypoxic hESC cultures
in the presence of TERT inhibitor at concentrations of 10µM and 20µM.

A

significant (p<0.05) decrease in Oct3/4 protein abundance was observed at both
inhibitor concentrations in hypoxia, and at 20µM in normoxia (Figure 3. 4 C, D).
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Additionally SSEA1 abundance was increased in the presence of 20µM of TERT
inhibitor in both normoxia and hypoxia (Figure 3.4 C-E).
Based on the observation that inhibition of TERT induced spontaneous
hESC differentiation, we investigated whether these changes coincided with
alterations in telomerase activity. To evaluate the effect of the TERT inhibitor on
telomerase activity in hESCs, the RQ-TRAP assay was performed on hESCs
cultured in hypoxia and normoxia for 3 days.

We observed a decrease in

telomerase activity in hESCs treated with 10µM of TERT inhibitor, and a
significant (p<0.05) telomerase activity reduction in the presence of 20µM TERT
inhibitor independent of oxygen condition tension (Figure 3.4B). As a whole,
these data indicate that pharmacological inhibition of the TERT subunit of
telomerase promotes a reduction in telomerase activity and results in
spontaneous differentiation in hESCs cultured in both hypoxic and normoxic
conditions.
We next investigated what effect antagonism of TERC would have on
hESCs cultured in normoxia and hypoxia conditions. H9 hESCs were treated
with 5µM of TERC inhibitor and analyzed by immunofluorescence to detect the
levels of pluripotency marker SSEA4 and differentiation marker SSEA1. In these
experiments SSEA4 was utilized as opposed to Oct3/4 used previously for TERT
inhibition. After performing TERT inhibition experiments we noticed that there
was a significant loss of cells due to the need of premeabilizing the fixed cells for
antibody access since OCT3/4 is an intracellular marker. The use of the cell
surface pluripotency marker SSEA4 on live cells limited this cell loss and gave
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Figure 3.5 - Inhibition of the telomerase RNA component (TERC) does not
cause spontaneous differentiation of hESCs. H9 hESCs were grown in
feeder-free conditions and treated with a small molecule inhibitor specific for the
TERC subunit of telomerase. (A) Immunofluorescence analysis of SSEA4 and
SSEA1 levels in hESCs treated with 5µM of TERC inhibitor for 3 days in hypoxia.
Scale bars represent 200µm. (B) Relative telomerase activity levels of whole-cell
lysates as measured by the Real-time quantitative TRAP (RQ-TRAP) assay.
Error bars represent SD, n=3. Different characters indicate significant differences
(p<0.05). (C) Flow cytometry data plots representing fluorescence signal for
hESCs treated with 5µM of TERC inhibitor for 3 days in 2% oxygen. Cells were
assayed for SSEA-4 and SSEA1 marker expression. (i, ii) Scatter plot with the
gated cell population shown for 2% oxygen and control. Populations were gated
based on morphology and comparison to their matched isotope control and
viability, according to forward scatter (FSC) and side scatter (SSC) pattern.
(Forward Scatter measures cell size and Side Scatter measures complexity).
SSEA1(iii) and SSEA-4 (iv) fluorescence in 2% oxygen (blue) and control (red)
relative to isotype control (black). Viability was determining using 7-AAD
staining. Mean fluorescence intensity plots derived from flow cytometry data
representing SSEA4(D) and SSEA1 (E) signal intensities, respectively, in hESCs
treated with 3µM and 5µM of TERC inhibitor for 3 days in 2% and 20% oxygen
Error bars represent SD, n=3. Different characters indicate significant differences
(p<0.05).
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more consistent results for pluripotency marker detection by immunofluorescence
and flow cytometry.

Similar to Oct3/4, SSEA4 is a marker characteristic of

undifferentiated hESCs (Yao et al., 2012). In TERC inhibitor treated hESCs, we
observed uniform SSEA4 fluorescence in normoxia and hypoxia cultured cells
(Figure 3.5A).

Additionally, we observed no apparent fluorescent signal for

SSEA1 in either culture condition (Figure 3.5A). Similar to the results observed
for immunofluorescence, when flow cytometry was performed on H9 hESCs
treated with TERC inhibitor (3µM and 5µM), we observed no significant (p>0.05)
changes in SSEA4 or SSEA1 abundance in hESCs treated and untreated with
the TERC inhibitor (Figure 3.5 C,D).
To validate the non-effect of TERC inhibition on hESC differentiation, we
investigated whether inhibition of TERC promoted a change in telomerase
activity. The RQ-TRAP assay was performed on hESCs treated with 3µM and
5µM of TERC inhibitor in hESCs cultured in normoxia and hypoxia conditions.
After 3 days of culture a significant decrease in telomerase activity was observed
in hESCs treated with 5µM of TERC inhibitor in both oxygen conditions (Figure
3.5B).

Interestingly, the effect of TERT and TERC inhibition on telomerase

activity was very similar (compare Figures 3.4B and 3.5B); however, inhibition of
TERC did not promote spontaneous hESC differentiation. Taken together, these
findings indicate that although telomerase activity can be decreased by
antagonism of both its catalytic (TERT) and RNA (TERC) components, this
reduction cannot universally promote spontaneous hESC differentiation.
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3.4 Normoxic and hypoxic culture conditions promotes differential
expression profiles of telomerase isoforms that is indicative of distinct
hESC states.
Based on the results demonstrating that TERC inhibition does not promote
spontaneous differentiation and that low oxygen conditions elevates TERT levels
and promotes its localization to the nucleus without significantly changes in
telomerase activity levels in hESCs, we next examined the transcript abundance
of several alternate splice variants of TERT, many of which are known to have no
telomerase activity (Park et al., 2009; Ulaner, G.A., et al., 2001; Anderson et al.,
2006).

These findings highlight the potential for hESC regulation based on

expression of different TERT isoforms.

To determine whether the changes

observed in our system operate in a splice variant dependent manner, we
investigated patterns of TERT isoform expression in hESCs cultured in normoxia
and hypoxia conditions.
To determine TERT isoform transcript levels in hESCs cultured in
normoxic and hypoxic conditions, we performed RT-PCR analysis using TERT
isoform specific primers. Agarose gel electrophoresis of amplified samples
revealed that constitutively spliced, full-length TERT, as well as the α- and βisoforms are expressed in H9 hESCs cultured in normoxia and hypoxia
conditions (Figure 3.6 A, B). However, both full-length TERT and the α-isoform
transcript abundance are reduced significantly (p<0.05) in hESCs cultured
hypoxic conditions compared to those in normoxia. (Figure 3. 6A, B). In addition,
the dual deletion variant (α- β-isoform) showed no difference in transcript levels
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Figure 3.6 - TERT splice variant expression profile changes in hESCs
cultured in hypoxia compared to normoxia microenvironments. hESCs
were cultured in feeder-free conditions in either normoxia (20% oxygen) or
hypoxia (2% oxygen) and harvested to monitor TERT isoform transcript
abundance. (A) A representative agarose gel electrophoresis of TERT splice
deletion variant (α-, β-, a-β-) mRNA transcript levels in hESCs grown under low
(2%) and high (20%) oxygen conditions for 5 days. (B) Densitometric analysis of
splice variant amplicons. Error bars represent SD, n=3. Different characters
indicate significant differences (p<0.05).
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between oxygen environments but were significantly (p<0.05) reduced compared
to the other TERT splice variants. Based on this differential expression pattern,
we sought to determine isoform-specific roles for the TERT splice variants in
hESCs in both oxygen conditions.
To reveal the potential biological roles for the TERT splice variants in
hESCs, steric-blocking Morpholino antisense oligonucleotides were utilized
(Postovit et al., 2008). In this study, fluorescently tagged morpholino
oligonucleotides (MO) were utilized to facilitate visualization in the cell MOs were
designed with a sequence complementary to α- (intron 5/exon 6) and β- (exon
8/intron 8) boundaries of the TERT pre-mRNA molecule (Figure 2.2).
To facilitate cellular MO uptake, hESCs were passaged in the presence of
the MO. Using immunofluorescence, we observed that MO specific for α and β
isoforms, as well as a scrambled control, were effectively taken up into hESCs
(Figure 3. 7 A). The efficiency of MO uptake was quantified using flow cytometry
examining fluorescence of the control MO in a culture of H9 hESCs (97.8%
efficiency) (Figure 3. 7B).
To confirm the specificity and effectiveness of the TERT MOs, RT-PCR
analysis was performed to measure constitutively spliced (full-length TERT) and
alternatively spliced TERT isoform transcript levels.

cDNA derived from H9

hESCs treated with either α- and β - MOs revealed a significant decrease in
splice variant transcript levels in the presence of TERT splice variant MO
compared to hESCs treated with the scrambled MO (Figure 3. 7C,D). We also
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Figure 3.7 - Steric-blocking morpholino antisense oligos alters TERT
splicing events in hESCs. hESCs were cultured in feeder-free conditions in
normoxia (20%) or hypoxia (2%) conditions in the presence of 10µM of MO.
hESCs were passaged in the presence of MO to facilitate uptake. (A)
Fluorescently labeled MO as observed by live cell fluorescence microscopy. MO
appears as green fluorescence hESCs. (B) Representative flow cytometry
analysis of hESCs carrying scrambled control MO. Percentage within the bar
indicates the number of cells positive for MO fluorescence. (C) Agarose gel
electrophoresis of PCR amplified cDNA samples shows a decrease in each
TERT variant of TERT α- and β-isoform specific MO’s mRNA relative to control
morpholino (C-MO) treated hESCs after treatment with 10µM MO for 72 hours.
(D) Densitometry analysis of TERT splices variant expression in the presence of
either MO. Error bars represent SD, n=3. Different characters indicate significant
differences (p<0.05).
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observed a significant (p<0.05) decrease of full length TERT in α- MO treated H9
cells but not in β-MO treated H9 cells (Figure 3. 7C,D).
To determine the effect of isoform depletion on pluripotency marker
expression, we assayed hESCs treated with MO for SSEA1 expression. There
was a significant increase in SSEA1 fluorescence in the presence of either αand β-isoform specific MOs but not the scrambled MO (Figure 8A). Based on the
observation that a significant increase in SSEA1 fluorescence occurs in the
presence of either α- and β-isoform specific MOs, we investigated whether these
changes coincided with alterations in telomerase activity. To evaluate the effect
of the α- and β-isoform specific MOs on telomerase activity in hESCs, the RQTRAP assay was performed on H9 hESCs treated with either α- and β – MOs.
We observed a significant (p<0.05) telomerase activity reduction in the presence
of both α- and β - MOs (Figure 3.8B). Taken together, these experiments
revealed that morpholino antisense oligonucleoties can block specific pre-mRNA
splicing of TERT and subsequently induce hESC differentiation based on SSEA1
expression, and this can effect on telomerase activity reduction in β – MOs
treated H9.
Splice variants have been detected during development displaying tissuespecific patterns influencing telomerase activity levels during differentiation
(Brenner et al., 1999). To further investigate TERT splice variant dependent
regulation of hESC differentiation, MO treated hESCs were assayed for a panel
of lineage specific markers using real-time quantitative RT-PCR (Figure 3. 8C).
hESCs cultured in the absence of bFGF for 72 hours to induce spontaneous
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Figure 3.8 – TERT morpholinos induce spontaneous hESC differentiation.
hESCs grown in feeder-free conditions were assayed for TERT isoform
expression after inhibition with TERT splice variant specific morpholino
oligonucleotides (MO). hESCs were passaged in the presence of MO to facilitate
uptake. Controls are hESCs grown in medium containing no bFGF to induce
spontaneous differentiation (embryoid body (EB) medium).
(A)
Immunofluorescence detection of SSEA1 (red fluorescence) in hESCs treated
with scrambled control morpholino (C-MO) and TERT α- and β-isoform specific
MO (green fluorescence in the overlay). Scale bars represent 200µm. (B)
Relative telomerase activity levels of whole-cell lysates as measured by the Realtime quantitative TRAP (RQ-TRAP) assay. Error bars represent SD, n=3.
Different characters indicate significant differences (p<0.05). (C) Real-time RTPCR analysis of hESCs treated with 10μM of MO for 3 days. Graphs show real
time RT-PCR analysis for various markers: undifferentiated hESCs (Oct3/4,
Nanog), ectoderm (NeuroD1, PAX6), endoderm (GATA6, GATA4, alphafetoprotein), mesoderm (T). All samples were normalized to the large ribosomal
protein (RPLPO) as an internal control, and fold changes calculated using the
delta-delta-CT method. Error bars represent SD, n=3. Different characters
indicate significant differences (p<0.05).
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differentiation were used as a control. In the presence of both the α- and βisoform specific MO, there was a decrease in Oct3/4 and Nanog transcript levels
(Figure

3.8C).

Examining

germ

layer

specific

markers

for

ectoderm

differentiation, we observed a significant (p<0.05) increase in the marker
neurogenic differentiation factor 1 (NeuroD1) and paired box 6 (Pax6) (Figure
8B).

However, there were no significant (p>0.05) changes in markers

representative of endoderm and mesoderm lineages (Figure 3. 8C).

Taken

together, these results indicate that MO inhibition of specific TERT isoforms can
promote

spontaneous

hESC

differentiation.

Additionally,

the

specific

upregulation of the ectoderm specific marker NeuroD1 and Pax6 indicate that βisoform inhibition caused spontaneous hESC differentiation with a bias towards
neuroectoderm.
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Chapter Four:
Discussion
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The interactions between cells and their microenvironment are critical for
the regulation of inter- and intra-cellular processes. This is evident with hESCs,
where subtle changes in the microenvironment can induce dramatic alterations in
cellular phenotype. In this study we set out to determine the dynamic interaction
between hESCs and their microenvironment and the subsequent effects on
extra-telomeric role(s) of telomerase in human embryonic stem cell potency and
self-renewal. Specifically, we investigated the effects of low oxygen on hESC
self-renewal and pluripotency while we examined the resultant changes in
telomerase reverse transcriptase (TERT) expression, localization, and activity. In
doing so, we have confirmed that a low oxygen microenvironment (hypoxia)
promotes maintenance of an undifferentiated state in hESCs.

In addition,

hypoxia prompts direct changes in telomerase subunit expression and its
localization. Perturbation of the telomerase through antagonism of the TERT
(but not TERC) subunit, or specific splice variants of TERT, promotes
spontaneous hESC differentiation. Together, our findings suggest a direct link
between hypoxia and regulation of the hESC phenotype through extra-telomeric
mechanisms of TERT isoforms outside telomerase's typical role of telomere
synthesis/maintenance.
Many changes in protein expression have been observed in different
oxygen tensions (Bertout et al., 2008). However knowing which proteins are
expressed differently in varying oxygen tensions, and therefore which proteins
may promote pluripotency is important for the development of methods to
maintain hESC pluripotency and prevent their differentiation in culture. Hypoxia
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has been shown to promote pluripotency in hESCs (Simon et al., 2008), but the
mechanism by which this occurs in is not clear. Hypoxic environments have
previously been observed to support different facets of hESC biology. Recent
works have demonstrated the beneficial effect of hypoxia towards generation of
naïve hESCs that have characteristics of a true ground-state of pluripotency,
rather than a more differentiation primed derivative (Kim et al., 2011).
Additionally, hypoxia has been observed to promote the derivation of induced
pluripotent stem cells (Yoshida et al., 2009).
Our results demonstrate a reduced cell death coupled with an enhanced
maintenance of an Oct3/4-positive, SSEA1-negative undifferentiated state of
hESCs in hypoxia (2% oxygen) when compared to cells cultured in normoxia
(20% oxygen) conditions.

This work supports previous studies that have

demonstrated the beneficial effects of hypoxia on maintaining the undifferentiated
state in hESCs (Westfall et al., 2008; Mohyeldin et al., 2010). Similar to our
findings, hypoxic environments (5% oxygen) have previously been observed to
be beneficial for the maintenance of an undifferentiated hESCs state (Ezashi et
al., 2005).

However, contrasting data for this finding have been presented,

suggesting that hypoxia is not beneficial and dependent on the culture conditions
employed (Chen et al., 2009).

These contrasting results can potentially be

reconciled when one considers the differential growth and differentiation
characteristics between individual hESC lines (Allegrucci et al., 2006). These
differences may also stem from the specific concentration of oxygen employed.
In contrast to our study, previous research efforts have utilized 5% oxygen
72

environments.

It is likely that cell line characteristics and culture practices

combine to result in phenotypic changes in hESCs in the face of changing
oxygen tensions.
As a natural byproduct of oxidative phosphorylation in aerobic cells,
reactive oxygen species (ROS) are produced. The presence of ROS in a cell,
places that cell under increased oxidative stress (Haendeler et al., 2003; Held et
al., 2010).

Increased oxidative stress regulates TERT post-translationally by

ROS-mediated phosphorylation of TERT which then exports TERT out of the
nucleus into the cytoplasm through nuclear pores. As a result telomeres are
shortened, cell may enter replicative senescence, and the antiapoptotic effects of
TERT are decreased (Haendeler et al., 2003). In order to determine specific
intracellular regulatory changes that result from alterations in environmental
oxygen concentration, we analyzed TERT expression and localization along with
subsequent telomerase activity in hESCs. We observed an increased protein
abundance as well as nuclear localization of TERT in hESCs cultured in hypoxia
when compared to those in normoxia (Figure 3.3 A-C). However, no significant
difference in telomerase activity levels was apparent in hESCs cultured under
low or high oxygen tensions (Figure 3.3 D).
There are numerous oxygen sensitive genes and regulatory pathways that
are well-known in hESCs (Westfall et al., 2008). One of these groups that have a
potential link with telomerase activity is the hypoxia inducible factor (HIF) family
(Westfall et al., 2008). HIFs are known to play a fundamental role in the cellular
response to oxygen concentration (Patel et aI., 2010). Additionally, HIFs have
73

been shown to regulate self-renewal and pluripotency in hESCs cultured in low
oxygen conditions (Forristal et al., 2009). HIFs regulate the expression of over
200 genes, including those associated with apoptosis and proliferation
(Carruthers et aI., 2009).

Active HIF complexes exists as heterodimers

comprised of an O2-regulated alpha subunit, and a constitutively expressed beta
subunit (Majmundar et aI., 2010; Prabhakar et aI., 2012). HIF heterodimers
regulate transcriptional responses by binding to hypoxia-response elements
(HREs) on their target genes (Webb et aI., 2009; Prabhakar et aI., 2012).
Several studies have shown that HIFs have a role in the maintenance of
hESC pluripotency (Szablowska-Gadomska et al., 2011; Quail et al., 2011).
Interestingly, both telomerase (TERT, TERC) genes promoter sequences contain
consensus HRE sites which under hypoxic conditions, expression of these genes
has been shown to be up-regulated through the specific activities of HIF-1
transcription factors (Nishi et al., 2004). In addition recent evidence indicates
hypoxia induces the transcriptional activity both hTR and hTERT gene promoters
in a HIF dependent manner (Anderson et al., 2011). These data suggest a
potential link between hypoxia, HIF, telomerase activity, and TERT splice variant
expression in some human cell types. By extension, it is therefore possible that
alteration of HIFs may affect TERT regulation or splice variant expression in
hESCs, and explain the elevation of TERT protein expression regardless of
telomerase activity change in hypoxia conditions (Figure 3.3).
To further investigate the relationship between telomerase and hypoxia in
the context of hESC self-renewal and differentiation, we utilized small molecule
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inhibitors specific for the catalytic (TERT) and RNA (TERC) subunits of this
enzyme. A previous study showed that knockdown TERT in human embryonic
stem cells, induced their differentiation, reduced their proliferation, and caused
them to loss pluripotency (Yang et al. 2008). Conversely, over-expression of fulllength TERT in hESCs increases their proliferation and colony-forming ability and
suppressed their in vitro differentiation capabilities, (Yang et al. 2008). However,
these modulations of TERT/telomerase levels were carried out in the presence of
the telomerase RNA component (TERC). Interestingly, evidence suggests that
when TERC is knockdown, hTERT can interact with the RNA component of
mitochondrial RNA processing endoribonuclease (RMRP) to form a distinct
ribonucleoprotein complex that has RNA-dependent RNA polymerase (RdRP)
activity that produces double-stranded RNAs that can be processed into small
interfering (si)RNA (Maida et al., 2009).
Our findings indicate that although telomerase activity can be decreased
through inhibition of both the TERT and TERC subunits, this reduction cannot
universally promote spontaneous hESC differentiation as measured by SSEA1
expression (Figure 3.4, 3.5). This is evidenced by the fact that inhibition of TERT
prompted a rapid induction of hESC differentiation, whereas antagonism of
TERC was unable to promote any cellular change in hESCs. Interestingly, these
results were consistent between both normoxia and hypoxia.
Although hESCs are known to express both TERT and TERC genes, our
findings indicate that these two subunits may work independently of each other
when they are uncoupled. This highlights the potential for extra-telomeric roles
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of TERT in hESCs. In line with this hypothesis, recent data has shown that
TERT can modulate signaling through the canonical Wnt pathway by acting as a
transcriptional cofactor (Park et al., 2009; Greider 2012). Maida et al. have also
shown that knockdown of TERC increased TERT interaction with the RNA
component of the mitochondrial RNA processing endoribonuclease (RMRP) that
is involved in the production of siRNAs (Maida et al., 2009). There appears to be
many extra-telomeric roles of telomerase that do not require its reverse
transcriptase activity (Park et al., 2009; Chung et al., 2005). TERT appears to be
capable of activating Wnt/β-catenin signaling by mechanisms independent of
telomeric DNA synthesis (Park et al., 2009; Martínez et al., 2011) (Figure 4.9).
The Wnt family of proteins has known roles in a large number of cellular and
developmental systems (Logan et al., 2004). Signaling through the canonical
Wnt pathway has also been observed to play critical roles in the regulation stem
cell behavior in the microenvironment (Doble et al., 2007; Sokol et al., 2011).
In addition, modulation of Wnt signaling has been shown to be critical for
the proper maintenance of pluripotency and differentiation in mESCs (Nusse et
al., 2008; Ten Berge et al., 2011). Full-length, constitutively spliced TERT can
activate Wnt reporters, the Wnt axis in vivo, and in mESCs (Park et al., 2009).
These findings support a link between telomerase activity and stem cell
pluripotency. TERT potentially signals through the canonical Wnt pathway in an
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Figure 4.9. Alternative functions of telomerase. TERT has a role as a
transcriptional modulator of the Wnt–β-catenin (β-cat) signaling pathway. Wnt
activate the Wnt receptor at the plasma membrane of the cell then forms a
complex and regulate the Wnt-target genes. In addition, in the mitochondria,
TERT associates with the RNA component of mitochondrial and has role in
regulating oxidative damage-induced apoptosis. There might be the potential link
between the extra-telomeric function of TERT and Wnt/β-catenin signaling in
modulating signaling pathways in stem cells. Based on our findings, these
pathways may operate by regulating endogenous expression of alternative TERT
isoforms in hESCs. Figure adapted from et al., 2011.
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extra-telomeric fashion independent of TERC, suggesting a potential explanation
for the differential outcome observed from their pharmacological inhibition (Figure
4.9). It would be interesting to examine these extra-telomeric effects of
telomerase in hESCs and to determine whether they are mediated by alternate
splice variants of TERT.
Our results demonstrated that TERC inhibition does not promote
spontaneous differentiation and that low oxygen conditions elevates TERT levels
and promotes its localization to the nucleus without significantly changes in
telomerase activity levels in hESCs. Interestingly, when we examined for the
expression of specific alternate splice variants of TERT (that have partial
deletions in the reverse transcriptase (RT) domain), we observed differential
patterns of expression for the TERT isoforms between normoxia and hypoxia
conditions

(Figure

3.6).

Ezashi

et

al.

have

demonstrated

that

the

microenvironment can regulate alternate splicing of the FGF receptors (Ezashi et
al., 2011).

It also has been shown that telomerase/TERT modulates Wnt

signaling without its telomeric ability (Park et al., 2009). So it is possible that
alternate splice forms of TERT may be expressed in hESCs that don't contain
reverse transcriptase (telomeric) function and may act in an extra-telomeric
fashion to govern stem cell state (Figure 4.9).
Steric blocking of both specific α- and β-splice isoforms of TERT using MO
resulted in spontaneous hESC differentiation as indicated by increased SSEA1
marker levels (Figures 3.7, 3.8). However we observed a significant telomerase
activity reduction only in the presence of β–MOs (Figure 3. 8B). Blocking of a
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specific TERT splice sites also caused the increase and/or decrease of other
TERT isoforms and had opposing effects on the amount of full-length TERT
transcripts as well (Figure 3. 7C), which may cause different telomerase activity
for α- and β–MOs.
maintenance

of

an

In addition to the changes observed in relation to
undifferentiated

hESC

state,

when

cultures

were

supplemented with isoform specific MOs, there was also marked differences in
specific differentiated marker expression after the induction of spontaneous
differentiation. Enhanced expression of the marker NeuroD1 and Pax6 in the
presence of β–MOs, and the absence of change in the other assayed factors
suggest a biased differentiation towards the ectodermal lineage.
Morpholino oligonucleotides (MO) have previously been leveraged to
modify TERT splicing in human prostate carcinoma cells (Ahmed et al., 2008).
Oligonucleotide exposure promoted a decrease in the full-length hTERT
transcript with a concomitant increase in alternatively spliced transcripts (Ahmed
et al., 2008).

The resultant effect was an inhibition of telomerase activity,

reduction of cell growth, and induction of apoptosis that was independent of
telomere-shortening (Ahmed et al., 2008). Our data are in agreement with those
from small molecule inhibition of specific telomerase subunits, wherein
antagonism of TERT promoted hESC differentiation in a mode independent of
oxygen tensions. These findings suggest that TERT can promote phenotypic
changes in hESCs in a splice isoform-dependent manner.
The generation and function of alternatively spliced TERT isoforms is
potentially regulated through multiple pathways (Figure 4.9). It has previously
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been observed that telomerase activity through alternative TERT splicing can be
mediated through the transforming growth factor β family pathway (Cerezo et al.,
2002). Alternatively, many different transcription factors, including c-Myc, bind to
the 330–base pair minimal TERT promoter and regulate transcription (Greider
2012). c-Myc has previously been implicated in the modulation of many cell
functions, including cell cycle regulation, proliferation, growth, differentiation, and
metabolism (Junttila et al,

2008).

It acts as a transcription factor for an

extremely large number of genes – suggested to be as high as 15% of the genes
in the genome (Fernandez et al, 2003).
Full-length TERT directly modulates Wnt/β-catenin signaling by acting as
a cofactor in a β-catenin transcriptional complex with BRG1 on gene promoters
for c-Myc and Cyclin D1 in the mouse (Sarin et al., 2005; Shkreli et al., 2012). It
has been shown this extra-telomeric role of full length TERT is conserved in a
TERT mutant without reverse transcriptase (telomeric) function (Park et al.,
2009), supporting the possibility that alternative splice forms of TERT, many of
which carry natural deletions in the RT domain, might also serve in similar extratelomeric roles to modulate gene transcription in stem cells.

This further

highlights the potential link between the extra-telomeric function of TERT and
Wnt/β-catenin signaling in modulating signaling pathways in stem cells (Figure
4.9).

Based on our findings, these pathways may operate by regulating

endogenous expression of alternative TERT isoforms in hESCs.
The differential expression pattern of TERT isoforms dependent on
oxygen

concentration

suggests

transcriptional
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regulation

dependent

on

environmental conditions.

It has previously been shown that cells can use

alternative splicing to rapidly and specifically alter gene expression, such as in
response to an environmental stress (Pleiss et al., 2007).

The presence of

alternate TERT splice variants indicates that these splicing events are not
random and suggest an important physiological role. This altered splice variant
pattern was accompanied with an increased cell survival (reduced cell death) and
maintenance of the undifferentiated state along with nuclear translocation of
TERT protein under hypoxic conditions (Figure 4.9). Many human genes are
known to be alternatively-spliced in response to hypoxia, and in some cases this
process has appear to be regulated by HIF1 (Hang et al., 2009; Pasanen et al.,
2010; Gang et al., 2011). Recent evidence shown alternative splicing can help
generating specific genes subunits that are expressed in a tissue-specific
manner during hypoxia via the HIF-1 pathway (Soñanez-Organis et al., 2012). It
also has been shown low O2 conditions alter TERT splice variant patterns in
various somatic cell types (Anderson et al., 2007). So it is possible that
alternative splicing is utilized in hESCs in order to mediate the cell's response to
hypoxia.
4.1.1Experimental limitations and future directions
To build on the data we have presented here, numerous experimental
extensions can be envisioned. Based on the contrasting data in relation to the
hypoxic response of hESCs, expansion of these works to include multiple stem
cell lines would be valuable. The known expression differences between hESC
lines may also shed interesting light on trends of TERT and TERC expression
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and the resultant levels of telomerase activity (Adewumi et al., 2007). Moreover,
these experiments can be applied to induced pluripotent stem cells (iPSC).
Hypoxic response and the resultant telomerase activity can be measured across
iPSC lines to determine differences in expression patterns between lines
reprogrammed using different methods.

Additionally, telomerase activity can

also be investigated during the reprogramming process to visualize trends in
relation to pluripotency factor expression.

Each of these studies could be

expanded to include investigation of TERT splice variant expression patterns to
visualize transcriptional regulation patterns. Moreover, MO antagonism of splice
variant expression could be examined during the reprogramming process to
determine if there are any resultant effects.
It would also be valuable to further investigate transcriptional regulation of
TERT isoforms from multiple angles. We can leverage the utility of the MO
technique and to knock down HIF1 expression in hESCs to see what changes
are observed during HIF1 silencing in differing oxygen conditions. Furthermore,
we can also examine TERT splice variant expression patterns as a result of HIF
antagonism. Alternatively, MO mediated knockdown of c-myc could be utilized to
observe changes that result in expression of TERT splice variants.

Over-

expression of specific TERT splice variants could also be used to determine
whether the isoforms confer greater resistance to spontaneous differentiation and
increase proliferation in hESCs.
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Based on our data, the most logical extension of this work involves
investigation of splice variant patterns during differentiation.

MOs could be

utilized at multiple stages of hESC differentiation, using spontaneous or directed
differentiation protocols, to assay changes in the resultant lineages. As hypoxia
is already known to promote differentiation into certain lineages (Prado-Lopez et
al., 2010), combination of these experiments with different oxygen gradients
could provide valuable supplemental information on hESC phenotypic changes.
In conclusion, here we have demonstrated the link between changes in
microenvironmental oxygen concentrations and the subsequent effects on extratelomeric role(s) of telomerase reverse transcriptase (TERT) subunit of
telomerase. Additionally, we have presented the novel roles of specific TERT
splice isoforms in the regulation of hESC self-renewal and differentiation.
Together these data provide valuable insight into the microenvironmental control
of hESC state as well as highlight the potential extra-telomeric roles for TERT
isoforms within hESCs. Future investigation of the connection between TERT
isoforms, oxygen environments, and transcriptional regulation by factors such as
HIF will support the generation of a model for coupled extracellular intracellular
regulation of telomerase.
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